Valneva publie ses résultats du S1 2020 marqués par des avancées majeures et une forte position de trésorerie

NEXT STORY
Novartis announces Kymriah® meets primary endpoint at interim analysis of pivotal study in follicular lymphoma
PREV STORY
Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ERYTECH presenta gli sviluppi aziendali e la sua posizione finanziaria alla fine del primo trimestre 2020

author_avatar
NASDAQ Market News

Centessa Pharmaceuticals Demonstrates Proof-of-Mechanism from First Three PiMZ Subjects Dosed in Part B of Phase 1 Study Evaluating ZF874

author_avatar
NASDAQ Market News

Roche’s Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer

Data will be presented at the 2018 World Conference on Lung Cancer (WCLC) and ...

author_avatar
NASDAQ Market News